Giant cell myocarditis following COVID-19 successfully treated by immunosuppressive therapy
被引:3
|
作者:
Amiri, Afsaneh
论文数: 0引用数: 0
h-index: 0
机构:
Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, IranIran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
Amiri, Afsaneh
[1
]
Houshmand, Golnaz
论文数: 0引用数: 0
h-index: 0
机构:
Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, IranIran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
Houshmand, Golnaz
[1
]
Taghavi, Sepideh
论文数: 0引用数: 0
h-index: 0
机构:
Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, IranIran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
Taghavi, Sepideh
[1
]
Kamali, Monireh
论文数: 0引用数: 0
h-index: 0
机构:
Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, IranIran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
Kamali, Monireh
[1
]
Faraji, Mona
论文数: 0引用数: 0
h-index: 0
机构:
Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, IranIran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
Faraji, Mona
[1
]
论文数: 引用数:
h-index:
机构:
Naderi, Nasim
[1
]
机构:
[1] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Sch Med, Tehran, Iran
来源:
CLINICAL CASE REPORTS
|
2022年
/
10卷
/
08期
关键词:
COVID-19;
Giant cell;
myocarditis;
INJURY;
D O I:
10.1002/ccr3.6196
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
It has been shown that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), by coronavirus disease 2019 (COVID-19), can lead to multi-organ impairment including cardiac involvement and immunological problems. Acute myocarditis is one of serious and fatal complications of COVID-19. In this case report, we present a 46-year-old lady with a history of lichen planus dermatitis who has developed a rapidly progressive heart failure after an episode of COVID-19. The pathologic examination of her endomyocardial biopsy specimens was compatible with GCM, and she was successfully treated with a combined immunosuppressive therapy regimen.